In this issue of Curr Vasc Pharmacol, Pfeiffer et al.  and Glorioso et al.  report the efficacy and tolerability
of aliskiren/amlodipine single-pill combinations (SPCs) in patients with inadequate blood pressure (BP) response to
amlodipine or aliskiren monotherapy, respectively.
Keywords: Aliskiren, amlodipine, single-pill combinations, inadequate blood pressure control, monotherapy
Rights & PermissionsPrintExport